Interleukin-8 in alcoholic liver disease

Area of Science:

• Hepatology
• Immunology
• Gastroenterology

Background:

• Acute alcoholic hepatitis (AAH) presents with inflammation, neutrophilia, and liver neutrophil infiltration, often without infection.
• Cytokines like tumor necrosis factor (TNF) and interleukin-6 (IL-6) are elevated in AAH, correlating with disease severity.
• Interleukin-8 (IL-8), a potent neutrophil activator, is implicated in the inflammatory response in AAH.

Purpose of the Study:

• To investigate the role of interleukin-8 (IL-8) in the neutrophilia and hepatic neutrophil infiltrate characteristic of acute alcoholic hepatitis.
• To correlate IL-8 levels with clinical and laboratory indicators of disease severity in AAH patients.

Main Methods:

• Measurement of plasma and liver tissue levels of IL-8 in patients with AAH.
• Comparison of IL-8 levels in AAH patients with those in abstinent alcoholic cirrhotics and patients undergoing detoxification.
• Correlation analysis between IL-8 levels and neutrophil infiltration in liver tissue.

Main Results:

• Plasma and hepatic IL-8 levels are markedly elevated in patients with AAH.
• Highest IL-8 levels are observed in AAH patients who die within four weeks of admission.
• A strong correlation exists between hepatic IL-8 levels and neutrophil infiltration in the liver.
• Moderate increases in IL-8 are seen in alcoholic cirrhotics and patients admitted for detoxification.

Conclusions:

• Interleukin-8 (IL-8) plays a central role in the neutrophilia and hepatic neutrophil infiltrate observed in acute alcoholic hepatitis.
• IL-8 levels serve as a potential biomarker for disease severity and prognosis in AAH.
• Targeting IL-8 may offer a therapeutic strategy for managing acute alcoholic hepatitis.